Advertisement rdharma@digitalinsightresearch.in, Author at Pharmaceutical Business review - Page 3 of 56
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Sobi to buy Dova Pharmaceuticals in $915m deal

The deal to acquire Dova Pharmaceuticals includes an upfront payment of $27.50 (£22.35) per share in cash, as well as one non-tradeable contingent value right (CVR). Dova Pharmaceuticals